About Beacon Biosignals
Beacon Biosignals is a Healthcare company based in Boston (United States) founded in 2019 by Jacob Donoghue, Brandon Westover, Jarrett Revels, and Sydney Cash. AI-based EEG analysis is provided for healthcare providers. Beacon Biosignals has raised $27 million across 3 funding rounds from investors including General Catalyst, Casdin Capital and Andy Beck. The company has 47 employees. Beacon Biosignals has completed 1 acquisition, including Dreem. Its chief executive, as recorded, is Jacob Donoghue. Its website beacon.bio draws about 18 thousand monthly visits. Beacon Biosignals offers products and services including Dreem Headband and EEG Neurobiomarker Platform. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is BEACON BIOSIGNALS, INC. Its competitors include Ceribell, BrainScope and Mynd Analytics; 2 of its 3 listed competitors have raised funding.
Company details
Beacon Biosignals was founded in 2019 and is based in Boston, United States. Operations focus on the healthcare sector, where an AI platform for EEG analysis and diagnosis is utilized by professionals. Real-time brain activity is captured to support studies of neurological and psychiatric diseases. Data from the platform is employed to quantify treatment plans and identify suitable patient populations.
- Headquarters Boston, United States
- Employees 47
- Founders Jacob Donoghue, Brandon Westover, Jarrett Revels, Sydney Cash
- SectorsHealthcare
- Email••••••••
- Website beacon.bio
- Social LinkedIn X
- Legal Name Beacon Biosignals, Inc.
- Total Equity Funding$27M (USD)
in 3 rounds
- InvestorsGeneral Catalyst
& 2 more
- Employee Count47
- Investments & Acquisitions
Products & Services of Beacon Biosignals
Beacon Biosignals offers a comprehensive portfolio of products and services, including Dreem Headband and EEG Neurobiomarker Platform.
Wearable device for at-home EEG monitoring in clinical studies.
Platform for EEG data analysis in neurological research and trials.
Funding Insights of Beacon Biosignals
Beacon Biosignals has successfully raised a total of $27M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $27M
- Total Rounds 3
- First Round $27M
(Nov 2021)
- Investors Count 3
All 3 funding rounds of Beacon Biosignals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2026 | $11M | Series B | – | – | Palo Santo,Kicker Ventures |
| Oct 2025 | $103.28M | Series B | – | – | Innoviva,Google Ventures |
| Nov 2021 | $27M | Series A | – | General Catalyst |
3 investors in total: 2 institutional and 1 angel.
Investors in Beacon Biosignals
Beacon Biosignals has secured backing from 3 investors, including venture fund and angel investors. Prominent investors backing the company include General Catalyst, Casdin Capital and Andy Beck.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment and transformation services for entrepreneurs in technology and finance sectors. | generalcatalyst.com | |||
Investing in Life Sciences sectors like Healthcare and Biotechnology. | casdincapital.com | |||
AB Andy Beck | unknown_271f928b75434de1b |
Investor details for Beacon Biosignals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Beacon Biosignals
29 people are tracked at Beacon Biosignals (13 in leadership, 16 in team); the tracked headcount is 47.
| Name | Role | Group |
|---|---|---|
Jacob Donoghue | Co-Founder & CEO | Leadership |
Brandon Westover | Co-Founder | Leadership |
Jarrett Revels | Co-Founder & CTO | Leadership |
Sydney Cash | Co-Founder | Leadership |
David Matthews | Chief Business Officer | Leadership |
Yongbo Wang | Vice President Of Engineering | Leadership |
M Brandon Westover | Co-Founder | Leadership |
Ilan Goodman | VP Platform | Leadership |
Jacob Donoghue, MD PhD | Co-Founder and CEO | Leadership |
Jayne Nerrie | Program Management Director | Leadership |
Allison Braly | Vice President, Clinical Strategy And Operations | Leadership |
Leticia Soto | Vice President Of Quality | Leadership |
Megan Means, MSHR | Senior Director Of People & Talent | Leadership |
Eric Davies | Software Engineering Manager | Team |
Dave Kleinschmidt | Senior Algorithm/research Software Engineer | Team |
Chris de Graaf | Site Reliability Engineer | Team |
Matthew Brzezinski | Software Engineer III | Team |
Srihari Sritharan, Ph.D. | Business Development Manager | Team |
Mkrtich Vatinyan | Research Software Engineer | Team |
Kyle Soeltz | Senior Front-End Software Engineer | Team |
9 more people are available in the full profile.
Complete people profiles for Beacon Biosignals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beacon Biosignals
Beacon Biosignals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Dreem.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Sleep quality is monitored via Dreem's wearable EEG device. | dreem.com | Paris, France | 2014 | Jul 2023 | •••• |
Complete acquisition details for Beacon Biosignals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Beacon Biosignals
4 dated milestones of Beacon Biosignals across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Beacon Biosignals is founded.
- Funding First funding round of $27.0M.
- Acquisition Acquires Dreem.
- Funding Latest funding round, Series B,.
Competitors of Beacon Biosignals
Beacon Biosignals has 3 listed competitors in our database, 2 of them funded. They include Ceribell, BrainScope and Mynd Analytics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ceribell.com | 2014 | Mountain View, United States | $187.52M | 218 | Portable EEG devices for point-of-care seizure diagnosis are provided. | |
| brainscope.com | 2006 | Bethesda, United States | $62.15M | 38 | Developer of AI-driven EEG platform transforming brain electrical activity into insights | |
| myndanalytics.com | 1999 | Aliso Viejo, United States | 105 | Provider of reference data and analytic tools for clinicians and researchers in psychiatry. |
Detailed competitors of Beacon Biosignals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Beacon Biosignals
The website of Beacon Biosignals (beacon.bio) receives about 17.9K visits a month.
- Monthly visits17.9K
▲ 2% vs previous month
Websites whose visitors overlap most with Beacon Biosignals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dreemhealth.com | 100% | 99K | #295,723 | View details |
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Beacon Biosignals (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Beacon Biosignals
Complete news archive for Beacon Biosignals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beacon Biosignals
Beacon Biosignals was founded in 2019 and raised its 1st funding round 2 years after it was founded.
Beacon Biosignals is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Jacob Donoghue is the CEO of Beacon Biosignals, as recorded in our data. They have also founded this company.
Beacon Biosignals is a funded company, having raised a total of $27M across 3 funding rounds to date. The company's 1st funding round was a Series A of $27M, raised on Nov 2021.
Beacon Biosignals has 47 employees.
Beacon Biosignals was founded in 2019 and is based in Boston, United States. Operations focus on the healthcare sector, where an AI platform for EEG analysis and diagnosis is utilized by professionals. Real-time brain activity is captured to support studies of neurological and psychiatric diseases. Data from the platform is employed to quantify treatment plans and identify suitable patient populations.
Beacon Biosignals's top competitors include Ceribell, BrainScope and Mynd Analytics.
Beacon Biosignals offers Dreem Headband and EEG Neurobiomarker Platform.
Beacon Biosignals has made 1 acquisition, including Dreem.
Beacon Biosignals has 3 investors. Key investors include General Catalyst, Casdin Capital, and Andy Beck.
Beacon Biosignals operates through Beacon Biosignals, Inc..